Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma
Crossref DOI link: https://doi.org/10.1007/s11060-014-1612-1
Published Online: 2014-09-12
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lu, Lei
Saha, Dipongkor
Martuza, Robert L.
Rabkin, Samuel D.
Wakimoto, Hiroaki
Text and Data Mining valid from 2014-09-12